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ABSTRACT		The	poor	solubility	of	drug	substances	in	water	and	their	low	dissolution	rate	in	aqueous	G.I.T	fluid	often	leads	to	insufficient	bioavailability.	As	per	Biopharmaceutical	Classification	System	(BCS),	Olmesartan	be-longs	to	the	class-II	category	having	poor	solubility	and	high	permeability.	Since	only	dissolved	drug	can	pass	the	gastrointestinal	membrane,	the	proper	solubility	of	the	drug	is	ultimately	desired.	Its	oral	bioavail-ability	is	26%.	Hence,	an	attempt	was	made	to	enhance	its	solubility	by	formulating	solid	dispersions	using	different	techniques	viz.,	Melting,	Kneading,	Co-precipitation,	Solvent	evaporation	and	Physical	mixing	etc.,	Drug	and	carrier	(Urea)	in	different	ratios	like	1:	1,	1:	2,	1:	3	and	1:4	were	used	for	formulating	solid	disper-sions.	The	compatibility	of	the	drug	with	the	carrier	was	checked	by	FTIR	studies,	these	results	revealed	that	there	was	no	interaction	between	them.	The	angle	of	repose,	bulk	density,	tapped	density;	Carr’s	index	and	Hausner	ratio	were	calculated	for	the	micrometric	characterization	of	all	the	solid	dispersions.	The	drug	content	was	found	to	be	high	and	uniform	in	all	formulations.	The	prepared	Solid	dispersion	SEM4	(1:4)	showed	minimal	wetting	time	of	13	seconds	compared	with	the	other	 formulations.	 In	vitro	dissolution,	release	studies	in	Phosphate	buffer	pH	of	6.8	revealed	that	the	prepared	solid	dispersions	showed	faster	drug	release	compared	with	the	pure	drug.		The	in	vitro	dissolution	profile	showed	ascendency	on	increas-ing	the	carrier	concentration.	
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INTRODUCTION	Oral	bioavailability	of	drugs	depend	on	its	solubility	and	or	dissolution	rate,	therefore	major	problems	as-sociated	with	these	drugs	was	its	very	low	solubility	
in	biological	fluids,	which	results	into	poor	bioavaila-bility	after	oral	administration.	Poor	aqueous	solubil-ity	is	one	of	the	major	hurdles	in	the	development	of	new	drugs	into	oral	dosage	forms	since	dissolution	is	the	first	step	in	the	absorption	of	drugs.	The	solubility	and	dissolution	behavior	of	a	drug	are	key	determi-nants	 to	 its	 oral	 bioavailability.	An	 improvement	of	oral	bioavailability	of	poorly	water-soluble	drugs	re-mains	one	of	the	most	challenging	aspects	of	drug	de-velopment[1].	There	are	several	methods	available	for	which	drug		dissolution	rate	or	solubility		can	be	en-hanced,	 includes	 micronization,	 nanonization,	 salt	formation,	 eutectic	mixture,	 precipitation,	 inclusion	complexes,	solid	dispersions	etc.,	The	 solid	 dispersion	 was	 introduced	 in	 the	 early	1970’s,	refers	to	a	group	of	solid	products	consisting	of	at	least	two	different	components,	generally	a	hy-drophilic	matrix	and	a	hydrophobic	drug[2].	 In	solid	dispersion	systems,	a	drug	may	exist	as	in	amorphous	form	in	polymeric	carriers	and	this	may	result	in	im-proved	solubility	and	dissolution	rates	as	compared	with	crystalline	material.	The	mechanisms	for	the	en-hancement	 of	 dissolution	 rate	 of	 solid	 dispersions	have	been	proposed	by	several	 investigators.	Drugs	molecularly	 dispersed	 in	 polymeric	 carriers	 may	achieve	 the	highest	 levels	 of	 particle	 size	 reduction	
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and	 surface	 area	 enhancement,	which	 result	 in	 im-proved	dissolution	[3].	Drugs	belonging	to	class	II	category	under	Biophar-maceutical	Classification	System	(BCS)	are	generally	known	 for	 the	 characteristic	 features	 of	 inherently	high	 permeability	 through	 biomembranes	 and	 low	aqueous	 solubility.	 Solid	 dispersion	 technique	 has	been	used	for	a	wide	variety	of	poorly	aqueous	solu-ble	drugs	such	as	nimesulide,	ketoprofen,	tenoxicam,	nifedipine,	nimodipine,	ursodeoxycholic	acid	and	al-bendazole.	Various	hydrophilic	carriers,	such	as	pol-yethylene	glycols,	polyvinylpyrrolidone,	hydroxypro-pylmethylcellulose,	gums,	sugar,	mannitol,	and	urea	have	been	 investigated	 for	 improvement	of	dissolu-tion	 characteristics	 and	 bioavailability	 of	 poorly	aqueous	soluble	drugs[4].	Olmesartan	is	a	specific	angiotensin	II	type	(AT1)	re-ceptor	antagonist	used	in	the	treatment	of	hyperten-sion.	It	effectively	inhibits	the	AT1	mediated	vasocon-strictive	 and	 aldosterone-secreting	 effects	 of	 angio-tensin	 II	 and	 results	 in	 a	 decrease	 in	 vascular	 re-sistance	and	blood	pressure.	Its	oral	bioavailability	is	26%.	The	half-life	is	approximately	13	hours.	But	the	problem	with	this	potentially	useful	antihypertensive	agent	is	that	it	is	practically	insoluble	in	water	[5].	The	main	objective	 of	 this	work	 is	 to	develop	 solid	dispersions	of	Olmesartan	medoxomil	by	incorporat-ing	 urea	 as	 a	 carrier	 by	 different	 solid	 dispersion	techniques	to	enhance	its	dissolution	rate	and	solu-bility.	
MATERIALS	AND	METHODS	Olmesartan	 medoxomil	 was	 a	 gift	 sample	 from	Madras	Pharmaceuticals,	Chennai.	Urea	&	Methanol	were	obtained	from	Loba	Chemie,	Mumbai.	All	other	chemicals	used	were	of	analytical	grade.	
Calibration	of	Olmesartan	medoxomil	A	 standard	 curve	was	 prepared	with	 different	 con-centration	 (1	 to	 10μg/ml)	 using	 pH	 6.8	 phosphate	buffer	 solution.	 The	 absorbance	 of	 these	 solutions	was	 measured	 at	 λmax	 by	 UV-	 spectrophotometer.	The	calibration	graph	was	drawn	by	taking	the	con-centration	on	the	X	axis	and	respective	absorbance	in	the	Y	axis,	to	get	a	straight	line	as	per	like	Beer’s	law.	This	standard	curve	was	used	to	estimate	the	concen-tration	of	the	drug	release	from	the	formulation	dur-ing	the	in	vitro	dissolution	studies	[6].	
Fourier	 Transform	 Infrared	 spectroscopic	 stud-
ies	(FTIR)	FTIR	 Spectroscopic	 study	was	 carried	 out	 to	 check	the	 compatibility	 between	 drug	 and	 polymer.	 The	spectrum	 of	 Olmesartan	 medoxomil	 (pure	 drug),	Urea	 and	 its	 physical	mixture	were	 recorded	 using	Fourier	 transform	infrared	spectrometer	(Spectrum	RX-1	Perkin-Elmer,	German).	Samples	were	prepared	using	 KBr	 (Spectroscopic	 grade)	 discs	 by	means	 of	
hydraulic	pellet	press	at	a	pressure	of	five	tons	for	30	seconds	at	a	resolution	of	4cm-1	[7].	
Preparation	of	Solid	dispersion	Solid	dispersions	were	prepared	by	using	urea	as	a	carrier	 in	 different	 ratios	 by	 various	 techniques	namely	Melting,	Kneading,	Co-precipitation,	 Solvent	evaporation	 and	 Physical	 mixing	 etc.	 The	 various	compositions	of	drug	and	hydrophilic	carriers	were	shown	in	Table 1.	
Melting	method	In	melting	method	the	drug	and	carrier	(urea)	were	mixed	in	1:1,	1:2,	1:3	&	1:4	ratios	in	a	china	dish	and	heated	on	a	water	bath	until	it	is	completely	melted.	Then	the	molten	mass	is	poured	on	a	tile	and	cooled.	The	 solidified	mass	 is	 dried	 pulverized	 and	 passed	through	sieve	No,	40	and	stored	in	a	desiccator[8].	
Kneading	method	A	mixture	of	drug	(Olmesartan)	and	carrier	(urea)	in	different	ratios	(1:	1,	1:	2,	1:	3	&	1:4)	are	wetted	with	solvent	 (methanol)	 and	 water	 (1:1	 ratio)	 and	kneaded	thoroughly	for	30	minutes	in	a	glass	mortar.	The	paste	formed	is	dried	at	room	temperature	for	24	hours.	Dried	powder	is	scrapped,	crushed,	pulverized	and	passed	through	sieve	No.	40	and	stored	in	a	des-iccator	[9,	10].	
Co-precipitation	method	Olmesartan	medoxomil	solid	dispersion	is	prepared	by	Co-precipitation	method	using	carrier	urea,	in	pro-portions	viz.,	(1:	1,	1:2,	1:	3&1:4).	Accurately	weighed	carrier	 (urea)	 is	dissolved	 in	water	 and	 the	drug	 is	dissolved	 in	 required	 quantity	 of	 methanol.	 After	complete	dissolution,	the	aqueous	solution	of	the	car-rier	 is	 then	 poured	 into	 the	 organic	 solution	 of	 the	drug	 with	 continuous	 stirring	 and	 kept	 in	 a	 water	bath.	The	solvents	are	then	evaporated.	The	disper-sion	 is	 pulverized	 with	 pestle	 and	 mortar,	 sieved,	dried	and	stored	in	desiccators	[11].	
Solvent	evaporation	method	Olmesartan	medoxomil	solid	dispersion	is	prepared	by	solvent	evaporation	method	using	carrier	urea,	in	proportions	 viz.,	 (1:	 1,	 1:2,	 1:	 3&1:4).	 Dissolve	 the	drug	and	carrier	using	methanol	in	a	china	dish	and	then	it	is	heated	until	the	solvent	gets	evaporated	and	a	clear	film	of	drug	&	carrier	are	obtained.	Scrap	the	resultant	solid	dispersion	with	a	spatula.	Solid	disper-sions	 are	 pulverized	 in	 a	 mortar	 and	 pestle	 and	passed	through	sieve	No.40	before	packing	in	an	air-tight	container	[12].	
Physical	mixing	method	Using	this	method,	it	can	be	prepared	by	mixing	the	drug	and	carrier	in	various	ratios	(1:1,	1:	2,	1:3&	1:4)	in	 a	 glass	mortar.	The	 solid	mass	 is	 pulverized	 and	
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passed	 through	 sieve	No.	 40	 to	 get	 uniformly	 sized	particles	and	stored	 in	desiccators	until	 further	use	
[13].	
Micromeritic	studies	[14-16]	All	the	formulations	were	evaluated	for	bulk	density,	tapped	density,	the	angle	of	repose,	Compressibility	index	&	Hausner	ratio.	
Determination	of	percentage	practical	yield	[17]	The	%	practical	yield	of	all	the	prepared	formulations	was	found	out	using	𝑃𝑟𝑎𝑐𝑡𝑖𝑐𝑎𝑙	𝑦𝑖𝑒𝑙𝑑 = Practical	masstheoretical	mass × 100	
Determination	of	drug	content	Solid	dispersions	equivalent	to	10	mg	of	Olmesartan	medoxomil	were	weighed	accurately	and	dissolved	in	10	ml	of	methanol,	diluted	with	phosphate	buffer	pH	6.8		at	λmax	by	UV-spectrophotometer	[18].	
%	𝑑𝑟𝑢𝑔	𝑐𝑜𝑛𝑡𝑒𝑛𝑡 = Sample	absorbanceStandard	absorbance × 100	
Determination	of	wettability	Olmesartan	medoxomil	solid	dispersions	were	placed	in	a	sintered	glass	funnel	plunging	into	a	beaker	con-taining	water	such	that	the	surface	of	the	water	in	the	beaker	remains	at	the	same	level	of	formulation	in	the	funnel.	 Methylene	 blue	 and	 Amaranth	 powder	 lay-ered	uniformly	on	the	surface	of	various	formulations	in	 the	 funnel	 separately	 and	 the	 time	 required	 for	wetting	dye	powders	were	measured	[19].	
In	vitro	dissolution	studies	A	dissolution	study	was	carried	out	by	using	USP	ro-tating	 basket	 apparatus	 (Type	 I)	 for	 1	 hour,	with	 a	stirring	 rate	 of	 100	 rpm.	 Phosphate	 buffer	 pH	 6.8,	used	as	dissolution	medium	(900	ml)	and	the	temper-ature	was	maintained	at	37	±	0.5	ºC.	Solid	dispersions	equivalent	 to	40	mg	of	Olmesartan	medoxomil	was	filled	 in	 hard	 gelatin	 capsules	 used	 for	 dissolution	studies.	Samples	(5ml)	were	collected	at	regular	 in-terval	of	time	(10,	20,	30,	40,	50	&	60	min).	The	same	volume	of	fresh	buffer	solution	was	replaced	into	the	dissolution	 jar	 after	 each	 sample	withdrawal.	 Simi-larly,	the	dissolution	test	was	conducted	for	the	pure	drug.	The	absorbances	of	the	samples	were	measured	using	Ultraviolet	(UV)	spectrophotometer	at	λmax	af-ter	suitable	dilution	using	appropriate	blank.	[20,	21]	
RESULTS	AND	DISCUSSION	The	λmax	of	Olmesartan	medoxomil	was	determined	by	scanning	the	10µg/ml	of	the	drug	solution	in	phos-phate	buffer	solution	pH	6.8	by	UV-spectrophotome-ter.		It	showed	the	λmax	of	257	nm	and	obeys	the	Beer’s	law	within	 the	 concentration	 range	 of	 1-	 10	 µg/ml	
was	shown	in	Figure 1.	Linear	correlation	coefficient	obtained	was	r2	=	0.9999	for	its	calibration.	FTIR	 spectrum	 of	 Pure	 Olmesartan	 medoxomil	showed	 sharp	 characteristic	 peaks	 at	 3005.20,	1832.44,	 1707.06,	 1602.9,	 1502.60,	 1390.72,	1136.11,	 1089.92cm-1.	 	 All	 the	 above	 characteristic	peaks	 appear	 in	 the	 spectra	 of	 all	 binary	 systems	were	within	the	same	wave	number.	FTIR	studies	re-vealed	 that	 there	 was	 no	 interaction	 between	 the	drug	and	polymeric	carriers	and	shown	in	Figure 2(a-c).	
 
Figure 1: Standard curve of Olmesartan medoxomil	
 
(a) FTIR spectrum of Olmesartan medoxomil	
	
(b)FTIR spectrum of Urea 
 
(c)FTIR spectrum of Olmesartan medoxomil + Urea 
Figure 2: FTIR spectrum of Olmesartan medoxomil, 
Urea and Olmesartan medoxomil+urea 	
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Twenty	 formulations	were	prepared	using	a	carrier	(Urea)	 in	 different	 ratios	 by	 different	 (Melting,	Kneading,	Co-precipitation,	Solvent	evaporation	and	Physical	mixing)	methods	were	shown	in	Table 1.	The	results	of	%	practical	yield	indicated	that	there	was	no	considerable	loss	in	the	yield	during	the	pro-cess	 &	 the	 drug	 content	 in	 the	 range	 of	 94.8%	 to	98.5%	indicating	the	uniform	distribution	of	the	drug	in	the	formulations	were	depicted	in	Table 3.	Among	all	the	formulations	minimum	mean	wetting	time	(13	seconds)	was	observed	for	the	dispersion	containing	
urea	 (SEM4)	 prepared	 by	 Solvent	 evaporation	method.	 The	 results	 obtained	 for	 the	 wettability	study	was	shown	in	Table 3.	The	in	vitro	dissolution	testing	was	performed	for	60	minutes	to	ascertain	the	effect	of	formulations	on	im-mediate	 drug	 release	 enhancement.	 The	 enhance-ment	 of	 carrier	 on	 drug	 release	 from	 solid	 disper-sions	was	 evaluated	 by	 comparing	 the	 solubility	 of	drug	present	in	the	mixtures	as	well	as	the	pure	drug.		Pure	 Olmesartan	medoxomil	 exhibited	 a	 release	 of	34.9%	at	60	minutes.	There	was	a	very	low	release	of	
Table 1: Composition of Olmesartan medoxomil solid dispersion 
S.	No	 Formulation	Code	 Drug:	Carrier	 Drug	(Olmesartan)	 Carrier	(Urea)	 Techniques	Used	
1	 MM1	 1:1	 1gm	 1gm	 Melting	Method	
2	 MM2	 1:2	 1gm	 2gm	 Melting	Method	
3	 MM3	 1:3	 1gm	 3gm	 Melting	Method	
4	 MM4	 1:4	 1gm	 4gm	 Melting	Method	
5	 KM1	 1:1	 1gm	 1gm	 Kneading	Method	
6	 KM2	 1:2	 1gm	 2gm	 Kneading	Method	
7	 KM3	 1:3	 1gm	 3gm	 Kneading	Method	
8	 KM4	 1:4	 1gm	 4gm	 Kneading	Method	
9	 CPM1	 1:1	 1gm	 1gm	 Co	Precipitation	Method	
10	 CPM2	 1:2	 1gm	 2gm	 Co	Precipitation	Method	
11	 CPM3	 1:3	 1gm	 3gm	 Co	Precipitation	Method	
12	 CPM4	 1:4	 1gm	 4gm	 Co	Precipitation	Method	
13	 SEM1	 1:1	 1gm	 1gm	 Solvent	Evaporation	Method	
14	 SEM2	 1:2	 1gm	 2gm	 Solvent	Evaporation	Method	
15	 SEM3	 1:3	 1gm	 3gm	 Solvent	Evaporation	Method	
16	 SEM4	 1:4	 1gm	 4gm	 Solvent	Evaporation	Method	
17	 PM1	 1:1	 1gm	 1gm	 Physical	Mixing	Method	
18	 PM2	 1:2	 1gm	 2gm	 Physical	Mixing	Method	
19	 PM3	 1:3	 1gm	 3gm	 Physical	Mixing	Method	
20	 PM4	 1:4	 1gm	 4gm	 Physical	Mixing	Method	
Table 2: Micromeritic evaluation of Olmesartan medoxomil solid dispersion 
S.No	 Formula	Code	 Bulk	Den-sity(gm/ml)	 Tapped	Den-sity(gm/ml)	 Carr’s	In-dex	 Hausner	Ratio	 Angle	Of	Repose	
1.	 MM1	 0.43	 0.66	 34.848%	 1.534	 210811	
2.	 MM2	 0.54	 0.64	 15.625%	 1.185	 230491	
3.	 MM3	 0.52	 0.69	 24.637%	 1.326	 230721	
4.	 MM4	 0.43	 0.63	 31.746%	 1.465	 220051	
5.	 KM1	 0.47	 0.54	 12.962%	 1.148	 230441	
6.	 KM2	 0.43	 0.49	 12.244%	 1.139	 260281	
7.	 KM3	 0.46	 0.49	 6.122%	 1.065	 210471	
8.	 KM4	 0.45	 0.	53	 15.094%	 1.177	 220681	
9.	 CPM1	 0.43	 0.52	 17.307%	 1.2093	 230621	
10.	 CPM2	 0.34	 0.39	 12.820%	 1.147	 190701	
11.	 CPM3	 0.36	 0.40	 10.00%	 1.111	 240881	
12.	 CPM4	 0.36	 0.44	 18.181%	 1.222	 290421	
13	 SEM1	 0.41	 0.	55	 25.454%	 1.341	 180701	
14	 SEM2	 0.43	 0.	52	 17.307%	 1.209	 180801	
15	 SEM3	 0.46	 0.	53	 13.207%	 1.152	 200701	
16	 SEM4	 0.40	 0.49	 18.367%	 1.225	 210701	
17	 PM1	 0.41	 0.	52	 21.153%	 1.268	 210441	
18	 PM2	 0.42	 0.	50	 16.00%	 1.190	 230641	
19	 PM3	 0.44	 0.54	 18.518%	 1.227	 240181	
20	 PM4	 0.42	 0.	52	 19.230%	 1.238	 230281	
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the	pure	drug	which	was	 then	 increased	with	 solid	dispersions.	From	the	in	vitro	drug	release	profile,	it	could	be	seen	that	formulation	SEM4	containing	Urea	(1:4	ratio	of	drug:	carrier)	showed	higher	dissolution	rate	93.62%	at	1hour,	so	it	was	considered	as	the	overall	best	for-mulation.	The	in	vitro	drug	release	profile	of	solid	dis-persion	 formulations	 showed	 increased	 dissolution	rate	 compared	with	 the	 pure	 drug.	 The	 dissolution	rate	of	the	drug	in	solid	dispersion	formulations	was	increased	with	 the	 increment	 in	 carrier	 proportion	(1:4	>	1:3	>1:2	>	1:1).	The	increases	in	dissolution	rate	of	the	drug	in	solid	dispersions	were	reported	because	of	the	enhanced	wettability	 and	 hydrophilic	 nature	 of	 the	 carrier	 in	the	formulations.	The	best	formulation	was	selected	based	 on	 the	 results	 obtained	 from	 the	 wettability	and	in	vitro	release	studies.	
In	vitro	release	studies	revealed	that	the	solid	disper-sions	 prepared	 using	 Urea	 by	 various	 methods	showed	faster	drug	release	compared	with	pure	drug.	SEM4	(1:4)	was	selected	as	the	best	formulation	be-cause	of	its	faster	wetting	and	dissolution	rate	among	all	 formulations.	 The	 results	were	 shown	 in	Figure 
3(I-V).	
	
 
	
Table 3: % Practical yield, drug content &wetting time of Olmesartan medoxomil solid dispersion 
S.	No	 Formula	Code	 %Practical	Yield	 %Drug	Content	 Wetting	Time	(Sec)	
1.	 MM1	 95	 97.17	 44	
2.	 MM2	 95	 97.44	 38	
3.	 MM3	 95.5	 96.15	 31	
4.	 MM4	 95	 96.66	 19	
5.	 KM1	 96.6	 97.69	 39	
6.	 KM2	 96.5	 96.66	 35	
7.	 KM3	 95	 96.92	 27	
8.	 KM4	 95.3	 95.89	 16	
9.	 CPM1	 95.6	 98.46	 43	
10.	 CPM2	 94.8	 95.12	 39	
11.	 CPM3	 95	 95.64	 29	
12.	 CPM4	 95	 98.46	 18	
13	 SEM1	 96	 97.22	 36	
14	 SEM2	 95	 97.12	 30	
15	 SEM3	 95.6	 94.22	 23	
16	 SEM4	 96	 94.3	 13	
17	 PM1	 98	 96	 49	
18	 PM2	 98	 95	 43	
19	 PM3	 98.5	 96.5	 36	
20	 PM4	 97	 97	 30	
Pure	drug	 -	 -	 -	 95	
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Figure 3: In vitro dissolution studies of Olmesartan 
medoxomil solid dispersions (I. Melting method, II. 
Kneading method, III. Co-precipitation method, IV. 
Solvent evaporation method, V. Physical mixing 
method)	
CONCLUSION	The	rate	of	wetting	and	dissolution	rate	of	Olmesar-tan	medoxomil	from	solid	dispersion	was	found	to	be	significantly	higher	than	pure	drug.	In	conclusion,	de-velopment	of	the	solid	dispersions	could	be	a	promis-ing	alternative	method	to	attain	fast	dissolution	rate	and	solubility	which	may	lead	to	improvement	in	bi-oavailability	and	hence	better	patient	compliance.	
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